Patients who is diagnosed Hip osteoarthritis (Kellgren and Lawrence grade 4) due to development dysp
Conditions
Interventions
Sponsors
Homma Yasuhiro
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who have symptoms for more than 3 months 2.Patients who have continued pain even after taking NSAIDs for 6 week or more and who can not use NSAIDs for asthma and digestive tract ulcer 3. More than 20 years old 4. Other , patients who the doctor has determined that it is suitable for this clinical study
Exclusion criteria
Exclusion criteria: 1.Patients with a history of hip surgery 2. Patients with abnormal platelet counts in peripheral blood 3.Person who smokes a lot (Brinkmanindex>600) 4. Treatment with anticoagulants(Warfarin) 5. Uncontrolled diabetes mellitus : HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration 6. Patients with malignancy 7. Patients less than 6 months after onset of cardiac infarction or cerebral infarction 8. Predictive survival period is less than 1 year 9. Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis) 10.Dialysis patients 11. Compromised host 12.Requiring continued use of oral corticosteroid therapy 13. Less than 20 years old 14.Doctor has determined that it is not suitable for this clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy | — |
Countries
Japan
Contacts
Public ContactYosuke Masubuchi
Juntendo university
Outcome results
None listed